Medications starting with
Spain-
It is used to treat adult patients with mild to moderately severe Alzheimer's dementia.
Dosage form: patches, transdermal
Active substance Dosage rivastigmine 9 mg Manufacturer: Neuraxpharm Spain S.L.
-
It is used to treat adult patients with mild to moderately severe Alzheimer's dementia, helping to reduce the symptoms of this disease.
Dosage form: patches, transdermal
Active substance Dosage rivastigmine 18 mg Manufacturer: Neuraxpharm Spain S.L.
-
It is used in adults to prevent the formation of blood clots in the veins following hip or knee replacement surgery. It is also used to treat clots in the veins of the legs (deep vein thrombosis) and in the blood vessels of the lungs (pulmonary embolism), helping to prevent them from recurring.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 10 mg Manufacturer: Almus Farmaceutica S.A.U.
-
It is used in adults to prevent blood clots in the brain (stroke) or in other blood vessels in people with non-valvular atrial fibrillation. It is also used to treat blood clots in the leg veins (deep vein thrombosis) and in the lungs (pulmonary embolism), helping to prevent their recurrence. In children and adolescents weighing 30 kg or more, it is used to treat these clots after an initial treatment with injectable medications.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 15 mg Manufacturer: Almus Farmaceutica S.A.U.
-
It is used in adults to prevent the formation of blood clots in the brain (stroke) or in other blood vessels in people with an irregular heart rhythm called non-valvular atrial fibrillation. It is also used to treat blood clots in the veins of the legs (deep vein thrombosis) and in the lungs (pulmonary embolism), and to prevent them from recurring. In children and adolescents weighing more than 30 kg, it is used to treat these clots following initial treatment with injectable medications.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 20 mg Manufacturer: Almus Farmaceutica S.A.U.
-
It is used in adults to prevent the formation of blood clots in the veins following hip or knee replacement surgery, and to treat and prevent clots in the veins of the legs (deep vein thrombosis) and in the blood vessels of the lungs (pulmonary embolism).
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 10 mg Manufacturer: Laboratorios Alter S.A.
-
It is used in adults to prevent the formation of blood clots in the brain (stroke) or in other blood vessels in people with a type of irregular heart rhythm called non-valvular atrial fibrillation. It is also used to treat blood clots in the veins of the legs (deep vein thrombosis) and in the lungs (pulmonary embolism), and to prevent them from reappearing. In children and adolescents weighing 30 kg or more, it is used to treat and prevent the recurrence of these clots following initial treatment with injectable medications.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 15 mg Manufacturer: Laboratorios Alter S.A.
-
It is used in adults to prevent the formation of blood clots in the brain (stroke) or in other blood vessels if you suffer from non-valvular atrial fibrillation. It is also used to treat blood clots in the veins of the legs (deep vein thrombosis) and in the lungs (pulmonary embolism), and to prevent them from reappearing. In children and adolescents weighing 30 kg or more, it is used to treat and prevent the recurrence of these clots following initial treatment with injectable medications.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 20 mg Manufacturer: Laboratorios Alter S.A.
-
It is used in adults to prevent the formation of blood clots in the veins following hip or knee replacement surgery. It is also used to treat clots in the veins of the legs (deep vein thrombosis) and in the blood vessels of the lungs (pulmonary embolism), helping to prevent them from recurring.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 10 mg Manufacturer: Aurovitas Spain, S.A.U.
-
It is used in adults to prevent the formation of blood clots in the brain (stroke) or in other blood vessels if you suffer from non-valvular atrial fibrillation. It is also used to treat blood clots in the veins of the legs (deep vein thrombosis) and in the lungs (pulmonary embolism), and to prevent them from reappearing. In children and adolescents weighing 30 kg or more, it is used to treat and prevent the recurrence of these clots following initial treatment with injectable medications.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 15 mg Manufacturer: Aurovitas Spain, S.A.U.
-
It is used in adults to prevent the formation of blood clots in the brain (stroke) or in other blood vessels in people with a type of irregular heart rhythm called non-valvular atrial fibrillation. It is also used to treat blood clots in the veins of the legs (deep vein thrombosis) and in the lungs (pulmonary embolism), and to prevent them from reappearing. In children and adolescents weighing 30 kg or more, it is used to treat and prevent these clots following initial treatment with injectable medications.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 20 mg Manufacturer: Aurovitas Spain, S.A.U.
-
It is used in adults to prevent the formation of blood clots in the veins following hip or knee replacement surgery, and to treat or prevent clots in the veins of the legs (deep vein thrombosis) and in the blood vessels of the lungs (pulmonary embolism).
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 10 mg Manufacturer: Laboratorios Cinfa S.A.
-
It is used in adults to prevent the formation of blood clots in the veins following hip or knee replacement surgery. It is also used to treat blood clots in the veins of the legs (deep vein thrombosis) and in the blood vessels of the lungs (pulmonary embolism), helping to prevent them from recurring.
Dosage form: capsules, hard
Active substance Dosage rivaroxaban 10 mg Manufacturer: Laboratorios Cinfa S.A.
-
It is used in adults to prevent the formation of blood clots in the brain (stroke) or in other blood vessels if you have non-valvular atrial fibrillation. It is also used to treat blood clots in the leg veins (deep vein thrombosis) and in the lungs (pulmonary embolism), and to prevent their recurrence. In children and adolescents weighing over 30 kg, it is used to treat and prevent the recurrence of these clots after initial treatment with injectable medications.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 15 mg Manufacturer: Laboratorios Cinfa S.A.
-
It is used in adults to prevent the formation of blood clots in the brain (stroke) or in other blood vessels if suffering from non-valvular atrial fibrillation. It is also used to treat blood clots in the veins of the legs (deep vein thrombosis) and in the lungs (pulmonary embolism), helping to prevent them from reappearing. In children and adolescents weighing 30 kg or more, it is used to treat and prevent the recurrence of these clots following initial treatment with injectable medications.
Dosage form: capsules, hard
Active substance Dosage rivaroxaban 15 mg Manufacturer: Laboratorios Cinfa S.A.
-
It is used in adults to prevent the formation of blood clots in the brain or other blood vessels in people with non-valvular atrial fibrillation. It is also used to treat blood clots in the leg veins (deep vein thrombosis) and in the lungs (pulmonary embolism), helping to prevent them from reappearing. In children and adolescents weighing 30 kg or more, it is used to treat and prevent the recurrence of these clots following initial treatment with injectable medications.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 20 mg Manufacturer: Laboratorios Cinfa S.A.
-
It is used in adults to prevent blood clots in the brain (stroke) or in other blood vessels if you have non-valvular atrial fibrillation. It is also used to treat blood clots in the leg veins (deep vein thrombosis) and in the lungs (pulmonary embolism), and to prevent their recurrence. In children and adolescents weighing 30 kg or more, it is used to treat and prevent recurrence of these clots after initial treatment with injectable medications.
Dosage form: capsules, hard
Active substance Dosage rivaroxaban 20 mg Manufacturer: Laboratorios Cinfa S.A.
-
It is used in adults to prevent the formation of blood clots in the veins after hip or knee replacement surgery, and to treat clots in the veins of the legs (deep vein thrombosis) or in the blood vessels of the lungs (pulmonary embolism), also helping to prevent them from reappearing.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 10 mg Manufacturer: Laboratorios Combix S.L.U.
-
It is used in adults to prevent the formation of blood clots in the brain (stroke) or in other blood vessels in people with an irregular heart rhythm called non-valvular atrial fibrillation. It is also used to treat blood clots in the veins of the legs (deep vein thrombosis) and in the lungs (pulmonary embolism), and to prevent them from reappearing. In children and adolescents weighing 30 kg or more, it is used to treat and prevent these clots following initial treatment with injectable medications.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 15 mg Manufacturer: Laboratorios Combix S.L.U.
-
It is used in adults to prevent the formation of blood clots in the brain (stroke) or in other blood vessels in people with a type of irregular heart rhythm called non-valvular atrial fibrillation. It is also used to treat blood clots in the veins of the legs (deep vein thrombosis) and in the lungs (pulmonary embolism), and to prevent them from recurring.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 20 mg Manufacturer: Laboratorios Combix S.L.U.
-
It is used in adults to prevent the formation of blood clots in the veins following hip or knee replacement surgery. It is also used to treat blood clots in the veins of the legs (deep vein thrombosis) and in the blood vessels of the lungs (pulmonary embolism), helping to prevent them from recurring.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 10 mg Manufacturer: Kern Pharma S.L.
-
It is used in adults to prevent the formation of blood clots in the brain (stroke) or in other blood vessels if you suffer from non-valvular atrial fibrillation. It is also used to treat blood clots in the veins of the legs (deep vein thrombosis) and in the lungs (pulmonary embolism), helping to prevent them from reappearing. In children and adolescents weighing 30 kg or more, it is used to treat these clots following initial treatment with injectable medications.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 15 mg Manufacturer: Kern Pharma S.L.
-
It is used in adults to prevent the formation of blood clots in the brain (stroke) or in other blood vessels if suffering from non-valvular atrial fibrillation. It is also used to treat blood clots in the veins of the legs (deep vein thrombosis) and in the lungs (pulmonary embolism), and to prevent them from reappearing. In children and adolescents weighing 30 kg or more, it is used to treat and prevent the recurrence of these clots following initial treatment with injectable medications.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 20 mg Manufacturer: Kern Pharma S.L.
-
It is used in adults to prevent the formation of blood clots in the veins following hip or knee replacement surgery. It is also used to treat clots in the leg veins (deep vein thrombosis) and in the blood vessels of the lungs (pulmonary embolism), helping to prevent them from recurring.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 10 mg Manufacturer: Krka D.D. Novo Mesto
-
It is used in adults to prevent the formation of blood clots in the brain (stroke) or in other blood vessels in people with non-valvular atrial fibrillation. It is also used to treat blood clots in the leg veins (deep vein thrombosis) and in the lungs (pulmonary embolism), and to prevent them from recurring.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 15 mg Manufacturer: Krka D.D. Novo Mesto
-
It is used in adults to prevent the formation of blood clots in the brain (stroke) or in other blood vessels in people with non-valvular atrial fibrillation. It is also used to treat blood clots in the veins of the legs (deep vein thrombosis) and in the lungs (pulmonary embolism), helping to prevent them from reappearing. In children and adolescents weighing more than 30 kg, it is used to treat and prevent the recurrence of these clots following initial treatment with injectable medications.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban Igual a 20.00 mg mg Manufacturer: Krka D.D. Novo Mesto
-
It is used in adults to prevent the formation of blood clots in the veins following hip or knee replacement surgery. It is also used to treat blood clots in the veins of the legs (deep vein thrombosis) and in the blood vessels of the lungs (pulmonary embolism), helping to prevent them from recurring.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 10 mg Manufacturer: Laboratorios Normon S.A.
-
It is used in adults to prevent blood clots in the brain (stroke) or in other blood vessels if you have non-valvular atrial fibrillation. It is also used to treat blood clots in the leg veins (deep vein thrombosis) and in the lungs (pulmonary embolism), and to prevent their recurrence. In children and adolescents weighing 30 kg or more, it is used to treat and prevent recurrence of these clots after initial treatment with injectable medications.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 15 mg Manufacturer: Laboratorios Normon S.A.
-
It is used in adults to prevent the formation of blood clots in the brain (stroke) or in other blood vessels in people with a type of irregular heartbeat called non-valvular atrial fibrillation. It is also used to treat blood clots in the leg veins (deep vein thrombosis) and in the lungs (pulmonary embolism), and to prevent their recurrence.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 20 mg Manufacturer: Laboratorios Normon S.A.
-
It is used in adults to prevent the formation of blood clots in the brain (stroke) or in other blood vessels in people with an irregular heart rhythm called non-valvular atrial fibrillation. It is also used to treat blood clots in the leg veins (deep vein thrombosis) and in the lungs (pulmonary embolism), helping to prevent their recurrence. In children and adolescents weighing 30 kg or more, it is used to treat and prevent these clots after initial treatment with injectable medications.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 15.000 mg Manufacturer: Towa Pharmaceutical S.A.
-
It is used in adults to prevent the formation of blood clots in the brain (stroke) or in other blood vessels in people with an irregular heart rhythm called non-valvular atrial fibrillation. It is also used to treat blood clots in the leg veins (deep vein thrombosis) and in the lungs (pulmonary embolism), helping to prevent their recurrence. In children and adolescents weighing 30 kg or more, it is used to treat and prevent these clots after initial treatment with injectable medications.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 20.000 mg Manufacturer: Towa Pharmaceutical S.A.
-
It is used in adults to prevent the formation of blood clots in the veins after hip or knee surgery, and to treat or prevent blood clots in the veins of the legs (deep vein thrombosis) and in the blood vessels of the lungs (pulmonary embolism).
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 10 mg Manufacturer: Sandoz Farmaceutica S.A.
-
It is used in adults to prevent the formation of blood clots in the brain (stroke) or in other blood vessels if you have an irregular heart rhythm called non-valvular atrial fibrillation. It is also used to treat blood clots in the veins of the legs (deep vein thrombosis) and in the lungs (pulmonary embolism), and to prevent them from occurring again. In children and adolescents weighing 30 kg or more, it is used to treat these clots following initial treatment with injectable medications.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 15 mg Manufacturer: Sandoz Farmaceutica S.A.
-
It is used to reduce the risk of myocardial infarction or death from heart disease in adults with acute coronary syndrome, and to reduce the risk of clot formation in people with coronary or peripheral artery disease.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 2,5 mg Manufacturer: Sandoz Farmaceutica S.A.
-
It is used in adults to prevent the formation of blood clots in the brain (stroke) or in other blood vessels if suffering from non-valvular atrial fibrillation. It is also used to treat blood clots in the veins of the legs (deep vein thrombosis) and in the lungs (pulmonary embolism), and to prevent them from reappearing. In children and adolescents weighing 30 kg or more, it is used to treat and prevent the recurrence of these clots following initial treatment with injectable medications.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 20 mg Manufacturer: Sandoz Farmaceutica S.A.
-
It is used in adults to prevent the formation of blood clots in the veins following hip or knee replacement surgery. It is also used to treat clots in the veins of the legs (deep vein thrombosis) and in the blood vessels of the lungs (pulmonary embolism), helping to prevent them from recurring.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 10 mg Manufacturer: Laboratorio Stada S.L.
-
It is used in adults to prevent the formation of blood clots in the brain (stroke) or in other blood vessels in people with an irregular heartbeat called non-valvular atrial fibrillation. It is also used to treat blood clots in the veins of the legs (deep vein thrombosis) and in the lungs (pulmonary embolism), and to prevent them from occurring again. In children and adolescents weighing more than 30 kg, it is used to treat these clots following initial treatment of at least 5 days with injectable medications.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 15 mg Manufacturer: Laboratorio Stada S.L.
-
It is used in adults to prevent the formation of blood clots in the brain (stroke) or in other blood vessels if you suffer from non-valvular atrial fibrillation. It is also used to treat blood clots in the veins of the legs (deep vein thrombosis) and in the lungs (pulmonary embolism), and to prevent them from recurring. In children and adolescents weighing 30 kg or more, it is used to treat and prevent these clots following an initial treatment of at least 5 days with injectable medications.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 20 mg Manufacturer: Laboratorio Stada S.L.
-
It is used in adults to prevent the formation of blood clots in the veins following hip or knee replacement surgery. It is also used to treat blood clots in the veins of the legs (deep vein thrombosis) and in the blood vessels of the lungs (pulmonary embolism), helping to prevent them from recurring.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 10 mg Manufacturer: Tarbis Farma S.L.
-
It is used in adults to prevent blood clots in the brain (stroke) or in other blood vessels if you have non-valvular atrial fibrillation. It is also used to treat blood clots in the leg veins (deep vein thrombosis) and in the lungs (pulmonary embolism), and to prevent their recurrence. In children and adolescents weighing 30 kg or more, it is used to treat and prevent recurrence of these clots after initial treatment with injectable medications.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 15 mg Manufacturer: Tarbis Farma S.L.
-
It is used in adults to prevent the formation of blood clots in the brain or other blood vessels if they suffer from non-valvular atrial fibrillation. It is also used to treat blood clots in the leg veins (deep vein thrombosis) and in the lungs (pulmonary embolism), helping to prevent them from reappearing. In children and adolescents weighing 30 kg or more, it is used to treat blood clots following an initial treatment of at least 5 days with injectable medications.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 20 mg Manufacturer: Tarbis Farma S.L.
-
It is used in adults to prevent the formation of blood clots in the veins following hip or knee replacement surgery. It is also used to treat blood clots in the veins of the legs (deep vein thrombosis) and in the blood vessels of the lungs (pulmonary embolism), helping to prevent them from recurring.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 10 mg Manufacturer: Teva Gmbh
-
It is used in adults to prevent the formation of blood clots in the brain or other blood vessels in people with an irregular heartbeat called non-valvular atrial fibrillation. It is also used to treat blood clots in the leg veins (deep vein thrombosis) and in the lungs (pulmonary embolism), and to prevent them from reappearing. In children and adolescents weighing more than 30 kg, it is used to treat and prevent the recurrence of these clots following initial treatment with injectable medications.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 15 mg Manufacturer: Teva Gmbh
-
It is used in adults to prevent the formation of blood clots in the brain or other blood vessels in people with an irregular heart rhythm called non-valvular atrial fibrillation. It is also used to treat blood clots in the leg veins (deep vein thrombosis) and in the lungs (pulmonary embolism), and to prevent their recurrence. In children and adolescents weighing 30 kg or more, it is used to treat and prevent the recurrence of these clots after initial treatment with injectable medications.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 20 mg Manufacturer: Teva Gmbh
-
It is used in adults to prevent the formation of blood clots in the brain (stroke) or in other blood vessels in people with non-valvular atrial fibrillation. It is also used to treat blood clots in the veins of the legs (deep vein thrombosis) and in the lungs (pulmonary embolism), helping to prevent them from recurring. In children and adolescents weighing 30 kg or more, it is used to treat these clots following initial treatment with injectable medications.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 20 mg Manufacturer: Viatris Limited
-
It is used in adults to prevent the formation of blood clots in the veins after hip or knee replacement surgery. It is also used to treat clots in the veins of the legs (deep vein thrombosis) and in the blood vessels of the lungs (pulmonary embolism), helping to prevent them from recurring.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 10 mg Manufacturer: Vivanta Generics S.R.O.
-
It is used in adults to prevent the formation of blood clots in the brain (stroke) or in other blood vessels if suffering from non-valvular atrial fibrillation. It is also used to treat blood clots in the veins of the legs (deep vein thrombosis) and in the lungs (pulmonary embolism), and to prevent them from reappearing. In children and adolescents weighing 30 kg or more, it is used to treat and prevent the recurrence of these clots following initial treatment with injectable medications.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 15 mg Manufacturer: Vivanta Generics S.R.O.
-
It is used in adults to prevent the formation of blood clots in the brain (stroke) or in other blood vessels if you suffer from non-valvular atrial fibrillation. It is also used to treat blood clots in the veins of the legs (deep vein thrombosis) and in the lungs (pulmonary embolism), and to prevent them from reappearing. In children and adolescents weighing 30 kg or more, it is used to treat and prevent the recurrence of these clots following initial treatment with injectable medications.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 20 mg Manufacturer: Vivanta Generics S.R.O.
-
It is used to treat adult patients with Alzheimer's dementia (mild to moderately severe) and also for dementia associated with Parkinson's disease.
Dosage form: solution, oral
Active substance Dosage rivastigmine hydrogen tartrate 3,2 mg Manufacturer: Laboratorios Combix S.L.U.
-
It is used to treat mild to moderately severe Alzheimer's dementia in adults, as well as dementia in adult patients with Parkinson's disease.
Dosage form: solution, oral
Active substance Dosage rivastigmine hydrogen tartrate 3,199 mg Manufacturer: Ababor Pharmaceuticals S.L.